What Does Emergent BioSolutions Do?

Total employees1459
HeadquartersGaithersburg
Founded1998

Emergent BioSolutions is a global life sciences company dedicated to developing, manufacturing, and delivering solutions that protect or enhance life by addressing public health threats. The company's portfolio includes vaccines and therapeutics for infectious diseases, chemical, biological, radiological, and nuclear (CBRN) threats, and emerging health crises. Emergent BioSolutions collaborates with governments, NGOs, and commercial partners worldwide to provide preparedness and response solutions for critical health emergencies, aiming to make a meaningful impact on global health security.

Where Is Emergent BioSolutions's Headquarters?

HQ Function

Serves as the global corporate center, housing executive leadership, strategic planning, finance, legal, and other core administrative functions supporting the company's worldwide operations.

Notable Features:

Located in a prominent life sciences and biotechnology corridor in Montgomery County, Maryland. The facility is a modern office building designed to support corporate operations.

Work Culture:

A mission-driven environment focused on addressing critical public health challenges. The culture emphasizes scientific innovation, collaboration across diverse teams, and a strong commitment to quality, compliance, and ethical conduct in service of its public health mission.

HQ Significance:

The headquarters is central to Emergent BioSolutions' strategic direction and operational oversight, coordinating its global network of research, development, and manufacturing sites. Its location provides access to a rich talent pool and proximity to key U.S. government agencies.

Values Reflected in HQ: The headquarters' professional setting reflects the serious nature of Emergent's work in public health. Its strategic location underscores a commitment to being at the forefront of biopharmaceutical innovation and government collaboration.

Location:

Emergent BioSolutions maintains a significant global presence with key operations spanning North America (United States and Canada) and Europe (including Switzerland and the UK). Core functions supported globally include research and development, small- and large-scale manufacturing of vaccines and therapeutics, quality assurance, regulatory affairs, and commercial distribution. The company's products are supplied to governments and healthcare providers worldwide to address public health threats and prepare for health emergencies.

Street Address:

400 Professional Drive

City:

Gaithersburg

State/Province:

MD

Country:

USA

Where Else Does Emergent BioSolutions Operate Around the World?

Baltimore, Maryland, USA (Bayview Campus)

Address: 5901 East Lombard Street, Baltimore, MD 21224, USA

Strengthens U.S. domestic manufacturing capabilities for essential public health products and supports national biodefense preparedness efforts.

Lansing, Michigan, USA

Address: 3500 N. Martin Luther King Jr. Blvd., Lansing, MI 48906, USA

Serves as a cornerstone of U.S. preparedness against specific biothreats like smallpox and anthrax, with specialized manufacturing capabilities.

Winnipeg, Manitoba, Canada

Address: 155 Innovation Drive, Winnipeg, Manitoba R3T 5Y3, Canada

Supports the Canadian and international markets with specialized biopharmaceutical products and serves as a key R&D and manufacturing hub within Canada for Emergent.

Bern, Switzerland

Address: Rehhagstrasse 79, 3018 Bern, Switzerland

Provides essential travel vaccines for Europe and other international markets, contributing to global health and disease prevention for travelers.

Buying Intent Signals for Emergent BioSolutions

Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.

Notable news
Hiring actively
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
*Example signal, not calculated in real time

Who's Leading Emergent BioSolutions? Meet the Executive Team

As of April 2025, Emergent BioSolutions' leadership includes:

Joseph C. Papa - President and Chief Executive Officer
Richard S. Lindahl - Executive Vice President, Chief Financial Officer and Treasurer
Adam Havey - Executive Vice President and Chief Operating Officer
Jennifer Fox Carmichael - Executive Vice President, General Counsel and Corporate Secretary
Michele M. Brennan - Senior Vice President, Chief People Officer
Paul Williams - Senior Vice President, Products Head
Kathy L. Zoon, Ph.D. - Senior Vice President, Chief Quality and Regulatory Officer

Who's Investing in Emergent BioSolutions?

Emergent BioSolutions has been backed by several prominent investors over the years, including:

BlackRock Inc.
The Vanguard Group, Inc.
State Street Corporation
Dimensional Fund Advisors LP
Geode Capital Management, LLC

What Leadership Changes Has Emergent BioSolutions Seen Recently?

Hire5
Exits2

Emergent BioSolutions has undergone a significant leadership transformation over the past 12 months (approx. May 2023 - May 2024), appointing a new CEO, CFO, COO, and General Counsel, among other key leadership roles. This signals a period of strategic renewal and focus for the company.

Departures

Robert G. Kramer Sr., Robert G. Kramer Sr. retired as President and CEO after several years of service.
Richard S. Elms, Richard S. Elms resigned from his position as EVP and CFO.
Haywood Miller, Haywood Miller transitioned out of the Interim CEO role upon the permanent CEO appointment.

New Appointments:

Joseph C. Papa, Joseph C. Papa appointed as the new President and Chief Executive Officer.
Richard S. Lindahl, Richard S. Lindahl joined as the new EVP and Chief Financial Officer.
Adam Havey, Adam Havey was appointed to the role of EVP and Chief Operating Officer.
Jennifer Fox Carmichael, Jennifer Fox Carmichael took on the role of EVP, General Counsel and Corporate Secretary.
Michele M. Brennan, Michele M. Brennan was appointed as SVP, Chief People Officer.

What Technology (Tech Stack) Is Used byEmergent BioSolutions?

Discover the tools Emergent BioSolutions uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.

Emergent BioSolutions Email Formats and Examples

Emergent BioSolutions commonly uses the '@ebsi.com' email domain. Based on publicly available information and common corporate structures, a likely format involves the employee's last name followed by their first initial.

[lastname][firstinitial]@ebsi.com

Format

papaj@ebsi.com

Example

75%

Success rate

What's the Latest News About Emergent BioSolutions?

Emergent BioSolutions Investor RelationsMay 7, 2024

Emergent BioSolutions Reports Financial Results for First Quarter 2024

Emergent BioSolutions announced total revenues of $165.1 million for Q1 2024. The company highlighted progress in its core products and CDMO services, and reaffirmed its commitment to strengthening its financial foundation and executing its strategic plan under new leadership....more

Emergent BioSolutions Investor RelationsApril 23, 2024

Emergent BioSolutions Secures $75 Million HHS Contract for Ebanga™ (ansuvimab-zykl) Ebola Therapeutic

Emergent BioSolutions announced a contract valued at approximately $75 million by the U.S. Department of Health and Human Services (HHS) to supply Ebanga™, a licensed therapeutic for Ebola virus disease. This contract supports U.S. preparedness efforts....more

Emergent BioSolutions Investor RelationsFebruary 21, 2024

Emergent BioSolutions Appoints Joseph C. Papa as President and Chief Executive Officer

Emergent BioSolutions announced the appointment of Joseph C. Papa as President and CEO, and a member of the Board of Directors, effective February 21, 2024. Mr. Papa brings over 35 years of experience in the healthcare industry....more

Highperformr's free tools for company research

Explore Employees by Region or Country

See where a company’s workforce is located, by country or region.

View Funding Details

View past and recent funding rounds with amounts and investors.

Understand Revenue Insights

Understand company revenue estimates and financial scale.

Track Active Job Openings

Track active roles and hiring trends to spot growth signals.

Review Product and Offerings

Discover what a company offers—products, platforms, and solutions.

Get SIC or NAICS Codes

Get the company’s official SIC and NAICS classifications.

Analyze Website Traffic Trends

Analyze visitor volume, engagement, and top traffic sources.

Discover Social Profiles and Engagement

Explore LinkedIn, Twitter, and other active social profiles.

Identify Top Competitors

Identify top competitors based on similar business traits.

Research and Discover Companies with Highperformr — Smarter, Faster

Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.

Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.

  • Track intent signals to find buyers who are actively in-market
  • Enrich contacts and companies instantly, no need to switch tools
  • Automate workflows to stay ahead of every change
  • Connect your CRM & tools for seamless data sync and activation

Thousands of companies, including Emergent BioSolutions, are just a search away.